Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 9/20 | 0.35 |
| ▸ | HTR2C | P28335 | 9/20 | 0.35 |
| ▸ | HTR2B | P41595 | 5/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27399620 | 0.72 | APP (0.36) | MAPT | |
| SCHEMBL24074578 | 0.72 | TSHR (0.32) | — | |
| SCHEMBL22791773 | 0.72 | TSHR (0.36) | KDM4EALDH1A1LMNAMAPT | |
| SCHEMBL25974635 | 0.71 | SLC6A4 (0.37) | HTR2AKDM4EALDH1A1LMNAKMT2A | |
| SCHEMBL22249985 | 0.71 | HTR7 (0.39) | KDM4EALDH1A1GAA | |
| SCHEMBL13984459 | 0.70 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL23312577 | 0.70 | — | — | |
| SCHEMBL24713808 | 0.70 | — | — | |
| SCHEMBL24773785 | 0.68 | — | — | |
| SCHEMBL2936738 | 0.68 | KDM4E (0.61) | KDM4EALDH1A1DRD2DRD3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021078120-A1 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES | NOVARTIS AG (CH) | 2021-04-29 | — | — | WO | disclosed |